<DOC>
	<DOCNO>NCT00271258</DOCNO>
	<brief_summary>- Main objective : To evaluate clinical physiological tolerance sodium divalproate manic , mixed hypomanic episode bipolar disorder adolescent treat 6 month . - Secondary objective : To evaluate efficacy sodium divalproate improve manic , mixed hypomanic symptom .</brief_summary>
	<brief_title>Safety Study Sodium Divalproate Bipolar Disorder Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Adolescent boys girl age 13 18 inclusive Weighing 40 kg Capable understanding protocol Who give write consent , parent legal guardian unless adolescent pass his/her 18th birthday Presenting diagnostic characteristic manic , mixed hypomanic episode bipolar disorder establish accordance DSM IV , gather semistructured interview ( Mini International Neuropsychiatric Interview M.I.N.I . ) With score YMRS scale ( Young Mania Rating Scale ) &gt; = 14 manic mixed episode &gt; = 10 hypomanic episode Absence blood valproic acid inclusion visit Willing use effective contraception case girl childbearing potential . In case investigator satisfy him/herself psychological capacity patient understand undertake use contraception . Whose physiological test result normal : hepatic function , blood count , lipid level , fast blood glucose level , blood urea , blood ammonia , blood protein , serum creatinine level plasma ion General criterion : Pregnant girl , breastfeed pregnancy test positive ( blood beta HCG test ) Simultaneous participation another study 2 month precede selection patient Psychiatric criterion : Established known mental retardation Autistic disorder Established schizophrenia Schizoaffective disorder Somatic criterion : Medical organic disease CNS ( epilepsy , tumour etc . ) Any known renal , cardiac haematological disease , disease immune system Endocrine disorder and/or biochemical abnormality know exist moment inclusion Exclusion criterion link treatment Known hypersensitivity valproate sodium divalproate one constituent drug Hepatic disease : acute hepatitis , chronic hepatitis , past personal family history severe hepatitis particularly cause medicinal product , hepatic porphyria Treatment lamotrigine , ( Lamictal ) Treatment mefloquine , ( Lariam ) Any treatment base valproate Treatment methylphenidate ( Ritalin ) The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>